Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A C Keech

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Diabetologia|June 8, 2010
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesM-R Taskinen, P J Barter, C Ehnholm, et al.
The British Journal of Ophthalmology|November 1, 1995
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study GroupM L Harris, A J Bron, N A Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2015
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyK H Williams, D R Sullivan, A S Veillard, et al.
Diabetologia|January 17, 2013
Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyK H Chan, R L O'Connell, D R Sullivan, et al.
Diabetologia|November 6, 2010
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyT M E Davis, R Ting, J D Best, et al.
Lancet (London, England)|November 9, 2007
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialA C Keech, P Mitchell, P A Summanen, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Diabetologia|June 8, 2010
Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetesM-R Taskinen, P J Barter, C Ehnholm, et al.
The British Journal of Ophthalmology|November 1, 1995
Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study GroupM L Harris, A J Bron, N A Brown, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 4, 2015
Low alanine aminotransferase levels and higher number of cardiovascular events in people with Type 2 diabetes: analysis of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyK H Williams, D R Sullivan, A S Veillard, et al.
Diabetologia|January 17, 2013
Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) studyK H Chan, R L O'Connell, D R Sullivan, et al.
Diabetologia|November 6, 2010
Effects of fenofibrate on renal function in patients with type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) StudyT M E Davis, R Ting, J D Best, et al.
Lancet (London, England)|November 9, 2007
Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trialA C Keech, P Mitchell, P A Summanen, et al.
Pageof 3